Lisanne Smans, Eef Lentjes, Ad Hermus, Pierre Zelissen
OBJECTIVE: Patients with Addison’s disease require lifelong treatment with glucocorticoids. At present, no glucocorticoid replacement therapy (GRT) can exactly mimic normal physiology. As a consequence, under- and especially overtreatment can occur. Suboptimal GRT may lead to various side effects …